September 16, 2014 12:30 PM ET

Biotechnology

Company Overview of Zafgen, Inc.

Company Overview

Zafgen, Inc., a biopharmaceutical company, focuses on the provision of therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications comprising obesity and hyperphagia in Prader-Willi Syndrome patients, craniopharyngioma-associated obesity, and severe obesity in the general population. The company is also developing ZGN-839, a methionine aminopeptidase 2 inhibitor, which is in preclinical trials reduces the severity of nonalcoholic steatohepatitis and plasma glucose. Zafgen, Inc. was founded in 2005 and is headquartered in Cambridge, Massa...

One Broadway

8th Floor

Cambridge, MA 02142

United States

Founded in 2005

13 Employees

Phone:

617-401-3051

Key Executives for Zafgen, Inc.

Chief Executive Officer and Director
Age: 54
Total Annual Compensation: $520.0K
Chief Financial Officer and Principal Accounting Officer
Age: 51
Total Annual Compensation: $297.9K
Chief Medical Officer
Age: 43
Total Annual Compensation: $407.0K
Compensation as of Fiscal Year 2013.

Zafgen, Inc. Key Developments

Zafgen, Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter Ended June 30, 2014

Zafgen, Inc. announced unaudited consolidated financial results for the second quarter ended June 30, 2014. For the quarter, the company reported loss from operations of $5.986 million against $2.975 million a year ago. Net loss attributable to common stockholders was $6.443 million or $2.96 per diluted share against $3.190 million or $4.37 per diluted share a year ago.

Zafgen, Inc. Presents at Canaccord Genuity 34th Annual Growth Conference, Aug-14-2014 11:00 AM

Zafgen, Inc. Presents at Canaccord Genuity 34th Annual Growth Conference, Aug-14-2014 11:00 AM. Venue: InterContinental Hotel, 510 Atlantic Avenue, Boston, MA 02210, United States. Speakers: Thomas E. Hughes, Chief Executive Officer and Director.

Zafgen, Inc., Q2 2014 Earnings Call, Aug 13, 2014

Zafgen, Inc., Q2 2014 Earnings Call, Aug 13, 2014

Similar Private Companies By Industry

Company Name Region
Mercator MedSystems, Inc. United States
Glycotex, Inc. United States
Response Scientific, Inc. United States
Mirari Biosciences, Inc. United States
Comgenex LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 4, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Zafgen, Inc., please visit www.zafgen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.